HomeCompareEXAI vs MCD

EXAI vs MCD: Dividend Comparison 2026

EXAI yields 41.32% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXAI wins by $170.6K in total portfolio value
10 years
EXAI
EXAI
● Live price
41.32%
Share price
$4.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$249.1K
Annual income
$43,246.81
Full EXAI calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — EXAI vs MCD

📍 EXAI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXAIMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXAI + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXAI pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXAI
Annual income on $10K today (after 15% tax)
$3,512.40/yr
After 10yr DRIP, annual income (after tax)
$36,759.79/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, EXAI beats the other by $14,466.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXAI + MCD for your $10,000?

EXAI: 50%MCD: 50%
100% MCD50/50100% EXAI
Portfolio after 10yr
$163.8K
Annual income
$34,737.26/yr
Blended yield
21.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

EXAI
Analyst Ratings
1
Buy
4
Hold
Consensus: Hold
Price Target
$5.00
+3.3% upside vs current
Range: $5.00 — $5.00
Altman Z
0.6
Piotroski
2/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXAI buys
0
MCD buys
0
No recent congressional trades found for EXAI or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXAIMCD
Forward yield41.32%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$249.1K$78.5K
Annual income after 10y$43,246.81$26,227.70
Total dividends collected$189.2K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy
Analyst price target$5.00$351.76

Year-by-year: EXAI vs MCD ($10,000, DRIP)

YearEXAI PortfolioEXAI Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$14,832$4,132.23$10,815$334.85+$4.0KEXAI
2$21,599$5,728.06$11,826$491.71+$9.8KEXAI
3$30,906$7,795.46$13,123$730.06+$17.8KEXAI
4$43,494$10,424.97$14,853$1,100.07+$28.6KEXAI
5$60,250$13,711.40$17,257$1,690.61+$43.0KEXAI
6$82,219$17,751.08$20,752$2,667.01+$61.5KEXAI
7$110,613$22,638.80$26,103$4,354.83+$84.5KEXAI
8$146,820$28,464.55$34,794$7,437.78+$112.0KEXAI
9$192,408$35,310.27$49,926$13,461.60+$142.5KEXAI
10$249,124$43,246.81$78,550$26,227.70+$170.6KEXAI

EXAI vs MCD: Complete Analysis 2026

EXAIStock

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Full EXAI Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this EXAI vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXAI vs SCHDEXAI vs JEPIEXAI vs OEXAI vs KOEXAI vs MAINEXAI vs YUMEXAI vs QSREXAI vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.